نتایج جستجو برای: angiogenic aktmtorp70s6k mechanism

تعداد نتایج: 580410  

Journal: :Cardiovascular diabetology 2016
Sherin Bakhashab Fahad W Ahmed Hans-Juergen Schulten Ayat Bashir Sajjad Karim Abdulrahman L Al-Malki Mamdooh A Gari Adel M Abuzenadah Adeel G Chaudhary Mohammed H Alqahtani Sahira Lary Farid Ahmed Jolanta U Weaver

BACKGROUND Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with diabetes mellitus (DM). To identify the most effective treatment for CVD, it is paramount to understand the mechanism behind cardioprotective therapies. Although metformin has been shown to reduce CVD in Type-2 DM clinical trials, the underlying mechanism remains unexplored. CD34(+) cell-bas...

Journal: :Journal of Cancer Metastasis and Treatment 2022

Cancer is a group of diseases with significant morbidity and mortality. In cancer cells, where energy requirements are exceptionally high, angiogenesis, which the sprouting new blood vessels from pre-existing ones, an important process for tumour survival progression. Hence, extensive research in recent years focuses on discovery anticancer drugs that target angiogenesis. Several methodologies ...

Journal: :The Journal of clinical investigation 2005
Pouneh Kermani Dahlia Rafii David K Jin Paul Whitlock Wendy Schaffer Anne Chiang Loic Vincent Matthias Friedrich Koji Shido Neil R Hackett Ronald G Crystal Shahin Rafii Barbara L Hempstead

The neurotrophin brain-derived neurotrophic factor (BDNF) is required for the maintenance of cardiac vessel wall stability during embryonic development through direct angiogenic actions on endothelial cells expressing the tropomysin receptor kinase B (TrkB). However, the role of BDNF and a related neurotrophin ligand, neurotrophin-4 (NT-4), in the regulation of revascularization of the adult ti...

2016
Toshiki Iwai Masamichi Sugimoto Suguru Harada Keigo Yorozu Mitsue Kurasawa Kaname Yamamoto

Vascular endothelial growth factor (VEGF)-neutralizing therapy with bevacizumab has become increasingly important for treating colorectal cancer. It was demonstrated that second-line chemotherapy together with bevacizumab after disease progression (PD) on first-line therapy including bevacizumab showed clinical benefits in metastatic colorectal and breast cancers (ML18147 trial, TANIA trial). O...

Journal: :Journal of molecular endocrinology 2006
Sarah X Zhang Joshua J Wang Guoquan Gao Kyoungmin Parke Jian-xing Ma

It has been shown that the balance between vascular endothelial growth factor (VEGF), a major angiogenic stimulator, and pigment epithelium-derived factor (PEDF), a potent angiogenic inhibitor, is critical for the regulation of vascular permeability and angiogenesis. However, the regulation of the balance is largely unclear. The present study demonstrated that there is a reciprocal interaction ...

2014
Camila Bianco Pimentel Aparecida Machado de Moraes Maria Letícia Cintra

BACKGROUND Cryosurgery is an efficient therapeutic technique used to treat benign and malignant cutaneous diseases. The primary active mechanism of cryosurgery is related to vascular effects on treated tissue. After a cryosurgical procedure, exuberant granulation tissue is formed at the injection site, probably as a result of angiogenic stimulation of the cryogen and inflammatory response, part...

Journal: :Microscopy research and technique 2001
V Djonov A C Andres A Ziemiecki

The mammary gland life cycle is exemplified by massive, physiologically dictated changes in cell number and composition, architecture, and functionality. These drastic upheavals, by necessity, also involve the mammary endothelium, which undergoes angiogenic expansion during pregnancy and lactation followed by ordered regression during involution. In this review, we summarise data obtained using...

2011
Inês Domingues José Rino Jeroen A. A. Demmers Primal de Lanerolle Susana Constantino Rosa Santos

Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) is the major mediator of the angiogenic effects of VEGF. In addition to its well known role as a membrane receptor that activates multiple signaling pathways, VEGFR2 also has a nuclear localization. However, what VEGFR2 does in the nucleus is still unknown. In the present report we show that, in endothelial cells, nuclear VEGFR2 interacts w...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2002
Zvonimir S Katusic

Evidence continues to accumulate on the importance of NO in angiogenesis.1–7 A number of angiogenic substances, including vascular endothelial growth factor (VEGF), stimulate production of NO in endothelial cells.8,9 In vivo biosynthesis of NO is essential for angiogenesis induced by tissue ischemia.3 Angiogenesis is severely impaired in ischemic hindlimb of endothelial NO synthase (eNOS)defici...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2002
Emmanouil Chavakis Stefanie Dimmeler

The process of angiogenesis plays an important role in many physiological and pathological conditions. Inhibition of endothelial cell (EC) apoptosis providing EC survival is thought to be an essential mechanism during angiogenesis. Many of the angiogenic growth factors inhibit EC apoptosis. In addition, the adhesion of ECs to the extracellular matrix or intercellular adhesion promotes EC surviv...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید